These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2956130)

  • 1. The endocrine effects of spironolactone used as an antiandrogen.
    Young RL; Goldzieher JW; Elkind-Hirsch K
    Fertil Steril; 1987 Aug; 48(2):223-8. PubMed ID: 2956130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
    Lobo RA; Paul WL; Goebelsmann U
    Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hirsutism with spironolactone.
    Tremblay RR
    Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of androgenic disorders with dexamethasone: dose-response relationship for suppression of dehydroepiandrosterone sulfate.
    Redmond GP; Gidwani GP; Gupta MK; Bedocs NM; Parker R; Skibinski C; Bergfeld W
    J Am Acad Dermatol; 1990 Jan; 22(1):91-3. PubMed ID: 2137141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission.
    Carmina E; Lobo RA
    Fertil Steril; 1998 Jun; 69(6):1075-9. PubMed ID: 9627295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hirsutism with spironolactone.
    Cumming DC; Yang JC; Rebar RW; Yen SS
    JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of clinical response in hirsute women treated with spironolactone.
    Crosby PD; Rittmaster RS
    Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
    N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women.
    Steinberger E; Smith KD; Rodriguez-Rigau LJ
    J Clin Endocrinol Metab; 1984 Sep; 59(3):471-7. PubMed ID: 6235239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
    J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.